Zhaoquan Xing

551 total citations
13 papers, 445 citations indexed

About

Zhaoquan Xing is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhaoquan Xing has authored 13 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhaoquan Xing's work include Cancer Mechanisms and Therapy (2 papers), Neuroendocrine Tumor Research Advances (2 papers) and Extracellular vesicles in disease (2 papers). Zhaoquan Xing is often cited by papers focused on Cancer Mechanisms and Therapy (2 papers), Neuroendocrine Tumor Research Advances (2 papers) and Extracellular vesicles in disease (2 papers). Zhaoquan Xing collaborates with scholars based in China and Sweden. Zhaoquan Xing's co-authors include Zhaoxu Liu, Zhaoxin Guo, Zhonghua Xu, Zhiqing Fang, Yueqing Tang, Zunlin Zhou, Liwei Meng, Xiaoyu Guo, Wei Jiao and Sten Nilsson and has published in prestigious journals such as PLoS ONE, Food and Chemical Toxicology and Cell Death and Disease.

In The Last Decade

Zhaoquan Xing

13 papers receiving 444 citations

Peers

Zhaoquan Xing
Qian Ma China
Rut Porta Spain
Ebru Alp Türkiye
Qian Ma China
Zhaoquan Xing
Citations per year, relative to Zhaoquan Xing Zhaoquan Xing (= 1×) peers Qian Ma

Countries citing papers authored by Zhaoquan Xing

Since Specialization
Citations

This map shows the geographic impact of Zhaoquan Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaoquan Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaoquan Xing more than expected).

Fields of papers citing papers by Zhaoquan Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaoquan Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaoquan Xing. The network helps show where Zhaoquan Xing may publish in the future.

Co-authorship network of co-authors of Zhaoquan Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaoquan Xing. A scholar is included among the top collaborators of Zhaoquan Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaoquan Xing. Zhaoquan Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Zhou, Jie, Zhaoquan Xing, Yilei Xiao, et al.. (2022). The Value of H2BC12 for Predicting Poor Survival Outcomes in Patients With WHO Grade II and III Gliomas. Frontiers in Molecular Biosciences. 9. 816939–816939. 3 indexed citations
2.
Xu, Xiaofei, et al.. (2022). Genetic features of TP53 mutation and its downstream FOXA1 in prostate cancer. BioScience Trends. 16(3). 221–229. 4 indexed citations
3.
Meng, Liwei, Zhaoquan Xing, Zhaoxin Guo, Yue Qiu, & Zhaoxu Liu. (2021). Hypoxia-induced microRNA-155 overexpression in extracellular vesicles promotes renal cell carcinoma progression by targeting FOXO3. Aging. 13(7). 9613–9626. 29 indexed citations
4.
Qiu, Yue, Zhaoquan Xing, Zhaoxin Guo, & Zhaoxu Liu. (2021). Upregulation of AQP2 mediated by transcription factor FOXO1 inhibits TGF‑β‑induced fibrosis in human urothelial cells. Experimental and Therapeutic Medicine. 22(6). 1388–1388. 4 indexed citations
5.
Meng, Liwei, Zhaoquan Xing, Zhaoxin Guo, & Zhaoxu Liu. (2020). LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression. Cell Death and Disease. 11(12). 1063–1063. 33 indexed citations
6.
Dong, Zhaogang, Xiaoyan Sun, Jingjing Xu, et al.. (2019). Serum Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) mRNA Protected by Exosomes as a Potential Biomarker for Gastric Cancer. Medical Science Monitor. 25. 7770–7783. 27 indexed citations
7.
Guo, Zhaoxin, Zhaoquan Xing, Rui Xing, et al.. (2015). Baicalein inhibits prostate cancer cell growth and metastasis via the caveolin-1/AKT/mTOR pathway. Molecular and Cellular Biochemistry. 406(1-2). 111–119. 91 indexed citations
8.
Guo, Zhaoxin, Zhaoquan Xing, Zhiqing Fang, et al.. (2015). Somatostatin Derivate (smsDX) Attenuates the TAM-Stimulated Proliferation, Migration and Invasion of Prostate Cancer via NF-κB Regulation. PLoS ONE. 10(5). e0124292–e0124292. 16 indexed citations
9.
Fang, Zhiqing, Yueqing Tang, Wei Jiao, et al.. (2014). Nitidine chloride induces apoptosis and inhibits tumor cell proliferation via suppressing ERK signaling pathway in renal cancer. Food and Chemical Toxicology. 66. 210–216. 59 indexed citations
10.
Fang, Zhiqing, Yueqing Tang, Zunlin Zhou, et al.. (2013). Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway. PLoS ONE. 8(5). e62823–e62823. 131 indexed citations
11.
Fang, Zhiqing, Yueqing Tang, Wei Jiao, et al.. (2013). Nitidine chloride inhibits renal cancer cell metastasis via suppressing AKT signaling pathway. Food and Chemical Toxicology. 60. 246–251. 40 indexed citations
12.
Xing, Zhaoquan, Zunlin Zhou, Rong Yu, et al.. (2010). XAF1 expression and regulatory effects of somatostatin on XAF1 in prostate cancer cells. Journal of Experimental & Clinical Cancer Research. 29(1). 162–162. 7 indexed citations
13.
Xing, Zhaoquan, Rong Yu, Shuling Li, & Zhaoxu Liu. (2010). Regulatory effects of somatostatin on XAF1 in prostate cancer. Regulatory Peptides. 164(1). 47–47. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026